Epidermolysis bullosa acquisita

Clinics in Dermatology

Volumn 30, Issue 1, 2012, Pages 60-69

  Gupta, Rishu ^a   Woodley, David T ^a   Chen, Mei ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; COLLAGEN ANTIBODY; COLLAGEN TYPE 7; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INFLIXIMAB; METHOTREXATE; PREDNISONE; RITUXIMAB;

ARTICLE; BLISTER; BRUNSTING PERRY PEMPHIGOID; BULLOUS PEMPHIGOID; CLINICAL FEATURE; DIARRHEA; DISEASE ASSOCIATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EROSION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; MOUSE; MUCOUS MEMBRANE PEMPHIGOID; NAIL DISEASE; NONHUMAN; PATHOGENESIS; PEMPHIGOID; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; SCAR; SKIN FRAGILITY; SWEAT GLAND DISEASE; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING;

ADRENAL CORTEX HORMONES; ANIMALS; AUTOANTIBODIES; COLLAGEN TYPE VII; CYCLOSPORINE; DAPSONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; RARE DISEASES; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 83155188966     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.03.011     Document Type: Article

References (98)

1. Woodley D.T., Briggaman R.A., O'Keefe E.J., et al. Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984, 310:1007-1015.
2. Woodley D.T., Burgeson R.E., Lunstrum G., et al. The epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988, 81:683-687.
3. Gammon W.R., Woodley D.T., Dole K.C., et al. Evidence that basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigens. J Invest Dermatol 1985, 84:472-476.
4. Gammon W.R., Heise E.R., Burke W.A., et al. Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988, 91:228-232.
5. Gammon W.R., Briggaman R.A. Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus: disease of autoimmunity to type VII collagen. Dermatol Clin 1993, 11:535-547.
6. Lee C.W. Prevalences of subacute cutaneous lupus erythematosus and epidermolysis bullosa acquisita among Korean/oriental papulations. Dermatology 1998, 197:187.
7. Arpey C.J., Elewski B.E., Moritz D.K., Gammon W.R. Childhood epidermolysis bullosa acquisita: report of three cases and review of literature. J Am Acad Dermatol 1991, 24:706-714.
8. Gammon W.R. Epidermolysis bullosa acquisita. Semin Dermatol 1988, 7:218-224.
9. Keene D.R., Sakai L.Y., Lunstrum G.P., Morris N.P., Burgeson R.E. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 1987, 104:611-621.
10. Chen M., Marinkovich M.P., Veis A., et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components; a potential role in epidermal-dermal adherence in human skin. J Biol Chem 1997, 272:14516-14522.
11. Lapiere J.C., Woodley D.T., Parente M.G. Epitope mapping of type VII collagen: identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993, 92:1831-1839.
12. Jones D.A., Hunt S.W., Prisayanh P.S., et al. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol 1995, 104:231-235.
13. Woodley D.T., Reese M.J., Briggaman R.A., Gammon W.R. Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. J Clin Invest 1987, 179:1826-1830.
14. Park S.B., Cho K.H., Youn J.L., et al. Epidermolysis bullosa aquisita in childhood-a case mimicking chronic bullous dermatosis of childhood. Clin Exp Dermatol 1997, 22:220-222.
15. Callot-Mellot C., Bodemer C., Caux F., et al. Epidermolysis bullosa aquisita in childhood. Arch Dermatol 1997, 133:1122-1126.
16. Lapiere J.C., Chen J.D., Iwasaki T., et al. Type VII collagen specifically binds fibronectin via a unique subdomain within the collagenous triple helix. J Invest Dermatol 1994, 103:637-641.
17. Chen M., Keene D.R., Costa F.K., et al. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J Biol Chem 2001, 276:21649-21655.
18. Gammon W.R., Briggaman R.A., Woodley D.T., et al. Epidermolysis bullosa acquisita-a pemphigoid like disease. J Am Acad Dermatol 1984, 820-832.
19. Woodley D.T., Chang C., Saadat P., et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005, 124:958-964.
20. Sitaru C., Mihai S., Otto C., et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005, 115:870-878.
21. Woodley D.T., Ram R., Doostan A., et al. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006, 126:1323-1330.
22. Woodley D.T., Doostan A., Bandyopadhyay P., et al. The cartilage matrix protein subdomain of type VII collagen is a newly recognized antigenic and pathogenic epitope for epidermolysis bullosa acquisita. Am J Pathol 2007, 170:2009-2018.
23. Sitaru C., Chiriac M.T., Mihai S., et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006, 177:3461-3468.
24. Sitaru C. Experiment models of epidermolysis bullosa acquisita. Exp Dermatol 2007, 16:520-531.
25. Woodley D.T. Epidermolysis bullosa acquisita. Prog Dermatol 1988, 22:1.
26. Roenigk H.H., Ryan J.G., Bergfeld W.F. Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol 1971, 103:1-10.
27. Harman K.E., Whittam L.R., Wakelin S.H., et al. Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin. Br J Dermatol 1998, 139:1126-1127.
28. Stewart M.I., Woodley D.T., Briggaman R.A. Acquired epidermolysis bullosa and associated symptomatic esophageal webs. Arch Dermatol 1991, 127:373-377.
29. Gammon W.R., Briggaman R.A., Wheeler C.E. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 1982, 7:382-387.
30. Dahl M.G. Epidermolysis bullosa acquisita-a sign of cicatricial pemphigoid?. Br J Dermatol 1979, 101:475-483.
31. Wieme N., Lambert J., Moerman M., et al. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. Dermatology 1999, 198:310-313.
32. Tokuda Y., Amagai M., Yaoita H., et al. A case of inflammatory variant of epidermolysis bullosa acquisita: chronic bullous dermatosis associated with non scarring mucosal blisters and circulating IgG anti-type-VII-collagen antibody. Dermatology 1998, 197:58-61.
33. Kurzhals G., Stolz W., Meurer M., et al. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 1991, 127:391-395.
34. Yancey K.B. Cicatricial pemphigoid. Dermatology in general medicine 1998, 674-679. McGraw Hill, New York. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, M. Freedberg, K.F. Austen (Eds.).
35. Hashimoto T., Ishiko A., Shimizu H., et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol 1996, 134:336-339.
36. Rusenko K.W., Gammon W.R., Briggaman R.A. Type VII collagen is the antigen recognized by IgA anti-sub lamina densa autoantibodies. J Invest Dermatol 1989, 92:510. [abstract].
37. Bauer J.W., Schaeppi H., Metze D., et al. Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol 1999, 141:887-892.
38. Lee C.W. Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Dermatology 2000, 200:83-84.
39. Edwards S., Wakelin S.H., Wojnarowska F., et al. Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. Pediatr Dermatol 1998, 15:184-190.
40. Tanaka H., Ishida-Yamamoto A., Hashimoto T., et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 1997, 77:623-632.
41. Schmidt E., Hopfner B., Chen C., et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002, 147:592-597.
42. Fukumoto T., Umemura T., Higuchi M., et al. Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen. J Am Acad Dermatol 2004, 50:480-482.
43. Mayuzumi M., Akiyama M., Nishie W., et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol 2006, 155:1048-1052.
44. Hundorfean G., Neurath M.F., Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010, 10:2393-2403.
45. Chan L.S., Woodley D.T. Pemphigoid: bullous and cicatricial. Current therapy in allergy, immunology and rheumatology 1996, 5-93. McGraw Hill, St Louis. L.M. Lichtenstein, A.S. Fauci (Eds.).
46. Chen M., O'Toole E.A., Sanghavi J. Type VII collagen exists in human intestine and serves as an antigenic target in patients with inflammatory bowel disease. J Invest Dermatol 1997, 108:542.
47. Lohi J., Leivo I., Tani T., et al. Laminins, tenascin and type VII collagen in colorrectal mucosa. Histochem J 1996, 28:431-440.
48. Chan L.S., Vanderlugt C.J., Hashimoto T., et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998, 110:103-109.
49. Lever WF, Schaumburg-Lever G. Congenital disease (genodermatoses). In: Lever WF, Schaumburg-Lever G. Histopathology of the skin. Philadelphia: Lippincott; 1990. p. 78.
50. Richter B.J., McNutt N.S. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979, 115:1325-1328.
51. Ray T.L., Levine J.B., Weiss W., et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 1982, 6:242-252.
52. Fine J.D., Tyring S., Gammon W.R. The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol 1989, 92:27.
53. Briggaman R.A., Wheeler C.E. The epidermal-dermal junction. J Invest Dermatol 1975, 65:71-84.
54. Briggaman R.A., Schechter N.M., Fraki J. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med 1980, 160:1027-1042.
55. Nieboer C., Boorsma D.M., Woerdeman M.J. Epidermolysis bullosa acquisita: immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 1980, 102:383-392.
56. Yaoita H., Briggaman A., Lawley T.J. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 1981, 76:288-292.
57. Kushniruk W. The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 1973, 108:1143-1146.
58. Epstein J.H., Tuffanelli D.L., Epstein W.L. Cutaneous changes in the porphyrias. A microscopic study. Arch Dermatol 1973, 107:689-698.
59. Paller A.S., Queen L.L., Woodley D.T., et al. Organ specific, phylogenic and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol 1986, 86:376.
60. Gammon W.R., Briggaman R.A., Inman A.O. Differentiating anti-lamina lucida and antisublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984, 82:139-144.
61. Ghohestani R.F., Nicolas J.F., Roussele P. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997, 133:1102-1107.
62. Domloge-Hultsch N., Anhalt G.J., Gammon W.R., et al. Antiepiligrin cicatricial pemphigoid: a subepithelial bullous disorder. Arch Dermatol 1994, 130:1521-1529.
63. Chan L.S., Fine J.D., Briggaman R.A., et al. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 1993, 101:262-267.
64. Hoang-Xuan T., Robin H., Heller M., et al. Epidermolysis bullosa acquisita diagnosed by direct immunoelectron microscopy of the conjunctiva. Ophthalmology 1997, 104:1414-1420.
65. Chen M., Tahk S.H., Costa F.K., et al. Recombinant expression of full-length type VII collagen alpha chain: structural and functional characterization and implication for gene therapy. J Invest Deramtol 2000, 114:756. [abstract].
66. Chen M., Chan L.S., Cai X., et al. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997, 108:68-72.
67. Vodegel R.M., Kiss M., De Jong M.C.J.M., et al. The use of skin substrate deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. Eur J Dermatol 1998, 8:83-85.
68. 3. Arch Dermatol 2000, 136:227-231.
69. Feliciani C., Di Muzio M., Mohammad Pour S., et al. 'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. J Eur Acad Dermatol Venereol 2000, 10:243-247.
70. De Jong M.C.J.M., Bruins S., Heeres K., et al. Bullous pemphigoid and epidermolysis bullosa acquisita: differentiation by fluorescence overlay antigen mapping. Arch Dermatol 1996, 132:151-157.
71. Kazama T., Yamamoto Y., Hashimoto T., et al. Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. Br J Dermatol 1998, 138:593-601.
72. Megahed M., Scharfetter-Kochnek K. Epidermolysis bullosa acquisita-successful treatment with colchicine. Arch Dermatol Res 1984, 286:35-46.
73. Cunningham B.B., Kirchmann T.T., Woodley D.T. Colchicine for epidermolysis bullosa (EBA). J Am Acad Dermatol 1996, 34:781-784.
74. Ishii N., Hamada T., Dainichi T., et al. Epidermolysis bullosa acquisita: what's new?. J Dermatol 2010, 37:220-230.
75. Crow L.L., Finkle J.P., Gammon W.R., et al. Cleaning of epidermolysis bullosa acquisita on cyclosporine. A J Am Acad Dermatol 1988, 19:937-942.
76. Connolly S.M., Sander H.M. Treatment of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1987, 16:890.
77. Hallel-Halevy D., Nadelman C., Chen M., et al. Epidermolysis bullosa acquisita: update and review. Clin Dermatol 2001, 19:712-718.
78. Engineer L., Ahmed A.R. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001, 44:818-828.
79. Mutasim D.F. Management of autoimmune bullous diseases: pharmacology and therapeutics. J Am Acad Dermatol 2004, 51:859-877.
80. Kirtschig G., Murrell D., Wojnarowska F., et al. Interventions for mucous membrane pemphigoid / cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002, 138:380-384.
81. Saha M., Cutler T., Bhogal B., et al. Refractory epidermolysis bullosa acquisita: successful treatment with rituximab. Clin Exp Dermatol 2009, 34:e979-80.
82. Schmidt E., Benoit S., Brocker E.B., et al. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 2006, 142:147-150.
83. Crichlow S.M., Mortimer N.J., Harman K.E. A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita. Br J Dermatol 2007, 156:194-196.
84. Neidermeier A., Eming R., Pfütze M., et al. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies). Arch Dermatol 2007, 143:192-198.
85. Sadler E., Schafleitner B., Lanschuetzer C., et al. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. Br J Dermatol 2007, 157:417-419.
86. Kofler H., Wambacher-Gasser B., Topar G., et al. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 1997, 36:331-335.
87. Caldwell J.B., Yancey K.B., Engler R.J., et al. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1994, 31:827-828.
88. Mohr C., Sunderkotter C., Hildebrand A., et al. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol 1995, 132:824-826.
89. Harman K.E., Black M.M. High-dose intravenous immunoglobulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999, 140:864-874.
90. Gourgiotou K., Exadaktylou D., Aroni K., et al. Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2002, 16:77-80.
91. Campos M., Silvente C., Lecona M., et al. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol 2006, 31:71-73.
92. Segura S., Iranzo P., Martinez D.E., et al. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol 2007, 56:960-967.
93. Camara A., Becherel P.A., Bussel A., et al. Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy. Ann Dermatol Venereol 1999, 126:612-615.
94. Rook A.H., Jegasothy B.V., Heald P., et al. Extracoporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 1990, 112:303-305.
95. Miller J.K., Stricklin G.P., Fine J.D., et al. Remission of severe epidermolysis bullosa acquisita induced by extracoporeal photochemotherapy. Br J Dermatol 1995, 133:467-471.
96. Gordon K.B., Chan L.S., Woodley D.T. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. Br J Dermatol 1997, 136:415-420.
97. Furue M., Iwata M., Yoon H.-I., et al. Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-BMZantibody titre. J Am Acad Dermatol 1986, 14:873-878.
98. Gammon W.R., Murrell D.F., Jenison M.W., et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993, 100:618-622.